These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2411825)

  • 1. Immunity to herpes simplex virus: virus reactivation modulates lymphokine activity.
    Sheridan JF; Beck M; Aurelian L; Radowsky M
    J Infect Dis; 1985 Sep; 152(3):449-56. PubMed ID: 2411825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.
    Sheridan JF; Beck M; Smith CC; Aurelian L
    J Immunol; 1987 Feb; 138(4):1234-9. PubMed ID: 3027176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of guinea-pig immune functions by interleukin 2: critical role of natural killer activity in acute HSV-2 genital infection.
    Weinberg A; Basham TY; Merigan TC
    J Immunol; 1986 Nov; 137(10):3310-7. PubMed ID: 3021853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of herpes simplex virus type 1 replication in fibroblast cultures by human blood mononuclear cells.
    Leibson PJ; Hunter-Laszlo M; Hayward AR
    J Virol; 1986 Mar; 57(3):976-82. PubMed ID: 2419591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual NK cell clones lyse both tumor cell targets and herpes simplex virus-infected fibroblasts in the absence of interferon.
    Canessa A; Chatterjee S; Whitley RJ; Prasthofer EF; Grossi CE; Tilden AB
    Viral Immunol; 1990; 3(3):217-24. PubMed ID: 1701642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological alterations associated with recurrent herpes simplex genitalis.
    Cauda R; Laghi V; Tumbarello M; Ortona L; Whitley RJ
    Clin Immunol Immunopathol; 1989 May; 51(2):294-302. PubMed ID: 2539283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological responses of patients with recurrent herpes genitalis.
    Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F
    Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired natural killer cytotoxicity during recrudescence of recurrent herpes simplex virus type 1 infection.
    Kuo YC; Lin CY; Cheng SF; Lin CC; Liu WT
    Cancer Detect Prev Suppl; 1987; 1():51-5. PubMed ID: 3480065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF; Welsh RM
    J Immunol; 1986 May; 136(9):3481-5. PubMed ID: 2420892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-interferon antibody inhibits natural killer cell activity in HSV-2 genital infection in C57BL/6J mice.
    Wrzos H; Abt PL; Rapp F
    Intervirology; 1990; 31(2-4):230-40. PubMed ID: 1695621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medullasin enhances human natural killer cell activity by a mechanism other than the induction of interferons or interleukin-2.
    Aoki Y; Fukuchi K
    Jpn J Cancer Res; 1987 Jan; 78(1):68-73. PubMed ID: 2434455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human natural killer cells by herpes simplex virus type 1-infected cells.
    Bishop GA; McCurry L; Schwartz SA; Glorioso JC
    Intervirology; 1987; 28(2):78-88. PubMed ID: 2832348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lymphokine production in vitro by blood lymphocytes from patients with a defective or hyperactive immune system].
    Gronewold P; Northoff H; Kirchner H; Peter HH
    Immun Infekt; 1984 Nov; 12(6):287-97. PubMed ID: 6210244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-dependent augmentation of anti-K562 activity following short-term culture of null cell-enriched human blood lymphocyte populations.
    Bloom ET; Babbitt JT
    Immunobiology; 1985 Jul; 169(5):540-52. PubMed ID: 2412954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell cytotoxicity to herpes simplex virus-1-infected cells is not altered by pregnancy.
    Eriksen NL; Gonik B; Loo LS
    Am J Obstet Gynecol; 1991 Oct; 165(4 Pt 1):965-8. PubMed ID: 1659194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of herpes simplex virus on induced cell-mediated cytotoxicity in neonates and adults.
    Chin TW; Plaeger-Marshall S; Ank BJ; Pressman SR; Stiehm ER
    Nat Immun Cell Growth Regul; 1991; 10(5):237-46. PubMed ID: 1661847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.